Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies
OTC allergy drugs halt growth of prescription oral antihistamines
March 22nd, 2004
Following the switch of the former blockbuster prescription allergy drug Claritin to an over-the-counter (OTC) formulation in December 2002, leadership within the allergy treatment market has changed, according to recent findings from Ipsos PharmTrends, a syndicated service tracking consumer purchase behavior of both prescription (Rx) and OTC drugs, provided by Ipsos, the global marketing research firm. One year after the move to OTC, Claritin - along with other non-prescription drug introductions such as Alavert and generic loratadine - halted the growth of the prescription oral antihistamines market and ended the market leadership the segment had gained by significant...
Source: Health & Medicine Week (2004-03-22)
|
